Knowledge, attitude, and behaviors toward liver health and viral hepatitis-related liver diseases in Thailand.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
23 Dec 2021
23 Dec 2021
Historique:
received:
06
06
2021
accepted:
26
11
2021
entrez:
23
12
2021
pubmed:
24
12
2021
medline:
19
2
2022
Statut:
ppublish
Résumé
This study aimed to quantify and evaluate the knowledge and awareness toward liver health and diseases as well as explore the attitudes and knowledge toward screening, diagnosis, and treatment of liver disease among the Thai population.This is a cross-sectional, self-reported and web-based questionnaire study. Awareness, perceptions and attitudes toward liver-related health and diseases as well as screening, diagnosis and treatment of liver diseases were assessed among 500 Thai adults.Respondents were mostly ≥35 years (62.0%) and females (52.0%). While there was an overall awareness regarding viral hepatitis as the main etiology of liver failure/cancer, respondents expressed misperceptions that hint at social stigmatization or discrimination toward infected individuals. A significant proportion lacked knowledge of liver screening tests and relevant diagnostic tests for viral hepatitis-related liver diseases. Screening or treatment costs and perception of being healthy were among reasons for not seeking medical consultation when exposed to risk factors or diagnosed. Treatment practices of hepatitis included prescription medication (59.1%), functional foods (51.8%) and traditional treatment (28.2%). Multivariate analysis identified income, recent health screening status and being diagnosed with liver disease(s) as significant predictors of the knowledge, attitude, and behaviors of the Thai population toward liver diseases.This study highlighted a degree of misperception and lack of in-depth understanding toward hepatitis-related liver diseases including poor attitudes and knowledge toward screening, diagnosis, and treatment of liver diseases. Factors identified suggest an unmet need to encourage proactive health-seeking behaviors to reduce transmission risks of hepatitis-related liver diseases within the community.
Identifiants
pubmed: 34941122
doi: 10.1097/MD.0000000000028308
pii: 00005792-202112230-00098
pmc: PMC8702093
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e28308Subventions
Organisme : Gilead Sciences
ID : no
Informations de copyright
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to disclose.
Références
World Health Organization. Global Health Sector Strategy on Viral Hepatitis, 2016–2021 | Towards Ending Viral Hepatitis. Geneva: World Health Organization; 2016:1-56. Available at: https://apps.who.int/iris/bitstream/handle/10665/246177/WHO-HIV-2016.06-eng.pdf;jsessionid=F5934335456A761C7349258535E3E5EC?sequence=1 . Accessed December 14, 2020.
Wasitthankasem R, Posuwan N, Vichaiwattana P, et al. Decreasing hepatitis C virus infection in thailand in the past decade: evidence from the 2014 National Survey. PLoS One 2016;11:e0149362.
Leroi C, Adam P, Khamduang W, et al. Prevalence of chronic hepatitis B virus infection in Thailand: a systematic review and meta-analysis | Elsevier Enhanced Reader. Int J Infect Dis 2016;51:36–43.
Chonprasertsuk S, Vilaichone RK. Epidemiology and treatment of hepatocellular carcinoma in Thailand. Jpn J Clin Oncol 2017;47:294–7.
Posuwan N, Wanlapakorn N, Sintusek P, et al. Towards the elimination of viral hepatitis in Thailand by the year 2030. J Virus Erad 2020;6:100003.
Posuwan N, Wanlapakorn N, Sa-nguanmoo P, et al. The Success of a Universal Hepatitis B Immunization Program as Part of Thailand's EPI after 22 Years’ Implementation. PLoS One 2016;11:e0150499.
Sunanchaikarn S, Theamboonlers A, Chongsrisawat V, et al. Seroepidemiology and genotypes of hepatitis C virus in Thailand. Asian Pac J Allergy Immunol 2007;25:175–82.
Mohamed AA, El-Toukhy NETR, Said EM, et al. Hepatitis C virus: efficacy of new DAAs regimens. Infect Disord Drug Targets 2020;20:143–9.
Soliman H, Ziada D, Salama M, et al. Predictors for fibrosis regression in chronic HCV patients after the treatment with DAAS: Results of a real-world cohort study. Endocr Metab Immune Disord Drug Targets 2020;20:104–11.
Rattanavipapong W, Anothaisintawee T, Teerawattananon Y. Revisiting policy on chronic HCV treatment under the Thai Universal Health Coverage: sn economic evaluation and budget impact analysis. PLoS One 2018;13:e0193112.
Poovorawan, Kittiyod, Pan-Ngum, et al. Estimating the impact of expanding treatment coverage and allocation strategies for chronic hepatitis C in a direct antiviral agent era – PubMed. PLoS One 2016;11:e0163095.
Posuwan N, Vuthitanachot V, Chinchai T, Wasitthankasem R, Wanlapakorn N, Poovorawan Y. Serological evidence of hepatitis A, B, and C virus infection in older adults in Khon Kaen, Thailand and the estimated rates of chronic hepatitis B and C virus infection in Thais, 2017. PeerJ 2019;7:e7492.
Poovorawan K, Treeprasertsuk S, Thepsuthammarat K, Wilairatana P, Kitsahawong B, Phaosawasdi K. The burden of cirrhosis and impact of universal coverage public health care system in Thailand: Nationwide study. Ann Hepatol 2015;14:862–8.
Wanich N, Vilaichone RK, Chotivitayatarakorn P. High prevalence of hepatocellular carcinoma in patients with chronic hepatitis B infection in Thailand. Asian Pac J Cancer Prev 2016;17:2857–60.
Somboon K, Siramolpiwat S, Vilaichone RK. Epidemiology and survival of hepatocellular carcinoma in the central region of Thailand. Asian Pac J Cancer Prev APJCP 2014;15:3567–70.
Hirnschall, Gottfried. WHO | There's a reason viral hepatitis has been dubbed the “silent killer.” World Health Organization. Published September 2, 2015. Available at: http://www.who.int/mediacentre/commentaries/viral-hepatitis/en/ . Accessed September 29, 2020.
1 THB to USD | Convert Thai Baht to US Dollars | Xe. Available at: https://www.xe.com/currencyconverter/convert/?Amount=1&From=THB&To=USD . Accessed December 15, 2020.
Han WM, Colby DJ, Khlaiphuengsin A, et al. Large transmission cluster of acute hepatitis C identified among HIV-positive men who have sex with men in Bangkok, Thailand. Liver Int 2020;40:2104–9.
Ti L, Kaplan K, Hayashi K, Suwannawong P, Wood E, Kerr T. Low rates of hepatitis C testing among people who inject drugs in Thailand: implications for peer-based interventions. J Public Health 2013;35:578–84.
Mokaya J, McNaughton AL, Burbridge L, et al. A blind spot? Confronting the stigma of hepatitis B virus (HBV) infection – a systematic review. Wellcome Open Res 2018;3:29.
Burnham B, Wallington S, Jillson IA, et al. Knowledge, attitudes, and beliefs of patients with chronic liver disease. Am J Health Behav 2014;38:737–44.
Zacks S, Beavers K, Theodore D, et al. Social stigmatization and hepatitis C virus infection. J Clin Gastroenterol 2006;40:220–4.
Smith-Palmer J, Cerri K, Sbarigia U, et al. Impact of stigma on people living with chronic hepatitis B. Patient Relat Outcome Meas 2020;11:95–107.
Ha S, Timmerman K. Awareness and knowledge of hepatitis C among health care providers and the public: a scoping review. Can Commun Dis Rep 2018;44:157–65.
Darwish MA, Khaldi NMAl. Knowledge about hepatitis B virus infection among medical students in University of Dammam, Eastern Region of Saudi Arabia. Life Sci J 2013;10:861–7.
da Silva AS, de Santos LL, et al. Chronic liver disease prevention strategies and liver transplantation. Acta Cir Bras 2006;21:79–84.
Wait S, Kell E, Hamid S, et al. Hepatitis B and hepatitis C in southeast and southern Asia: challenges for governments. Lancet Gastroenterol Hepatol 2016;1:248–55.
Jin J, Sklar GE, Min Sen Oh V, Chuen Li S. Factors affecting therapeutic compliance: a review from the patient's perspective. Ther Clin Risk Manag 2008;4:269–86.
Teerawattananon Y, Kingkaew P, Koopitakkajorn T, et al. Development of a health screening package under the universal health coverage: the role of health technology assessment. Health Econ 2016;25: (Suppl 1): 162–78.
National Health Security Office, Thailand. Thailand: Universal Health Care Coverage Through Pluralistic Approaches: International Labour Organization; 2015:27. Available at: https://www.ilo.org/wcmsp5/groups/public/---ed_protect/---soc_sec/documents/publication/wcms_secsoc_6612.pdf . Accessed January 05, 2021.
Get free tests for hepatitis B and C, people urged after coverage pledge. Available at: https://www.nationthailand.com/news/30374139 . Accessed December 18, 2020.
Social Security Office | Thailand. Available at: https://www.sso.go.th/wpr/main . Accessed February 15, 2021.
Pan-genotypic Hep-C drug added to Thai health system. Make Medicines Affordable. Published January 22, 2021. Available at: https://makemedicinesaffordable.org/pan-genotypic-hep-c-drug-added-to-thailands-health-system/ . Accessed February 8, 2021.
Kanjanahattakij, Napatt, Kwankhao, et al. Herbal or traditional medicine consumption in a Thai worker population: pattern of use and therapeutic control in chronic diseases. BMC Complement Altern Med 2019;19:01–9.
Peltzer K, Pengpid S. The use of herbal medicines among chronic disease patients in Thailand: a cross-sectional survey. J Multidiscip Healthc 2019;12:573–82.
Gebrecherkos T, Girmay G, Lemma M, Negash M. Knowledge, attitude, and practice towards hepatitis B virus among pregnant women attending antenatal care at the university of gondar comprehensive specialized hospital, Northwest Ethiopia. Int J Hepatol 2020;2020:10.
Rajamoorthy Y, Taib NM, Munusamy S, et al. Knowledge and awareness of hepatitis B among households in Malaysia: a community-based cross-sectional survey. BMC Public Health 2019;19:47.
Ahmad A, Munn Sann L, Abdul Rahman H. Factors associated with knowledge, attitude and practice related to hepatitis B and C among international students of Universiti Putra Malaysia. BMC Public Health 2016;16:611.
Atlam S, Elsabagh H, Shehab N, Eldeen N. Knowledge, attitude and practice of Tanta University medical students towards hepatitis B and C. Int J Res Med Sci 2016;4:749–56.
Wasitthankasem R, Vichaiwattana P, Siripon N, et al. Liver disease burden and required treatment expenditures for hepatitis C virus (HCV) infection in Thailand: Implications for HCV elimination in the new therapeutic era, a population-based study. PLoS One 2018;13:e0196301.
Upala P, Apidechkul T, Tamornpark R, Chomchoei C, Yeemard F. Seroprevalence and factors associated with hepatitis B infection among the hill tribe adult population in Thailand: a cross-sectional study. BMC Infect Dis 2020;20:494.
Bierhoff M, Angkurawaranon C, Myat Min A, et al. Maternal hepatitis B infection burden, comorbidity and pregnancy outcome in a low-income population on the Myanmar-Thailand border: a retrospective cohort study. J Pregnancy 2019;2019:11.